Trial Profile
Bioequivalence of a premixed IV formulation of amiodarone [PM 101] vs a reference admixed IV formulation
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 29 Mar 2011
Price :
$35
*
At a glance
- Drugs Amiodarone (Primary)
- Indications Ventricular fibrillation; Ventricular tachycardia
- Focus Pharmacokinetics
- Sponsors Prism Pharmaceuticals
- 29 Mar 2011 New trial record